TRINETRA › Sectors › Healthcare
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) — share price, P/E and fundamentals
Yatharth Hospital & Trauma Care Services Limited (NSE: YATHARTH) closed at ₹926.90 on 30 Oct 2026, +14.3% over one year, against a 52-week range of ₹538.25 – ₹1,184.00.
In the quarter ended 30 Jun 2026 (consolidated, filed 10 Aug 2026) it reported revenue of ₹393 cr and net profit of ₹47 cr, a 12.0% net margin; revenue grew 52.3% and profit grew 4.3% year on year.
On four consecutive filed quarters its trailing P/E is 51.2; since 26 May 2025 its own P/E has ranged from 34.0 to 61.8 (median 46.2), and today's reading is higher than 72% of those 354 trading days.
From the balance sheet dated 31 Mar 2026: return on equity 10.4%, ROCE 12.9%, debt-to-equity 0.14, Piotroski F-score 6 of 9.
Against 65 Healthcare peers on NSE: Net margin higher than 41% of 63 sector peers; PBT margin higher than 35% of 63 sector peers; ROE higher than 27% of 63 sector peers.
Key figures
| Last close | ₹926.90 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -19.9% / +29.0% / +14.3% |
| 52-week low – high | ₹538.25 – ₹1,184.00 |
| Market capitalisation | ₹8,931 cr |
| Trailing P/E | 51.2 |
| Price / book | 4.94 |
| EV / EBITDA | 26.4 |
| Earnings yield | 2.0% |
| TTM EPS | ₹18.11 |
| TTM net profit | ₹174 cr |
| Quarter revenue | ₹393 cr |
| Quarter net profit | ₹47 cr |
| Net margin | 12.0% |
| Revenue growth (YoY) | +52.3% |
| Profit growth (YoY) | +4.3% |
| Return on equity | 10.4% |
| ROCE | 12.9% |
| Debt / equity | 0.14 |
| Current ratio | 3.87 |
| Free cash flow | ₹-112 cr |
| Piotroski F-score | 6 / 9 |
| Average daily turnover (50 days) | ₹32.7 cr |
Against Healthcare peers
| Metric | YATHARTH | Peer median | Percentile |
|---|---|---|---|
| Net margin | 11.99 | 12.89 | 41 |
| PBT margin | 15.59 | 17.68 | 35 |
| ROE | 10.42 | 13.87 | 27 |
| ROCE | 12.93 | 17.26 | 25 |
| Debt / equity | 0.14 | 0.11 | 55 |
| Cash conversion | 1.20 | 1.25 | 47 |
| Trailing P/E | 51.19 | 43.07 | 56 |
| P/B | 4.94 | 6.02 | 41 |
Questions
What is the P/E ratio of Yatharth Hospital & Trauma Care Services Limited?
Yatharth Hospital & Trauma Care Services Limited's trailing P/E is 51.2, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 26 May 2025 its P/E has ranged 34.0–61.8.
What were Yatharth Hospital & Trauma Care Services Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Yatharth Hospital & Trauma Care Services Limited reported revenue of ₹393 cr and net profit of ₹47 cr (consolidated), filed with the exchange on 10 Aug 2026.
What is Yatharth Hospital & Trauma Care Services Limited's ROE?
Return on equity is 10.4% based on the balance sheet dated 31 Mar 2026.
Does Yatharth Hospital & Trauma Care Services Limited have debt?
Debt-to-equity is 0.14 on the balance sheet dated 31 Mar 2026.
What is YATHARTH's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, YATHARTH traded between ₹538.25 and ₹1,184.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.